ReviewThe oncologist2018
Management of Adverse Events Associated with Cabozantinib Therapy in Renal Cell Carcinoma.
Manuela Schmidinger et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
50 papers cite it
this paperpooled ittrialcites it